Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 985-994

  Isozaki, Yuka ^a   Hoshino, Isamu ^a   Nohata, Nijiro ^a   Kinoshita, Takashi ^a   Akutsu, Yasunori ^a   Hanari, Naoyuki ^a   Mori, Mikito ^a   Yoneyama, Yasuo ^a   Akanuma, Naoki ^a   Takeshita, Nobuyoshi ^a   Maruyama, Tetsuro ^a   Seki, Naohiko ^a   Nishino, Norikazu ^b   Yoshida, Minoru ^c   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

^c RIKEN   (Japan)

Author keywords

AEG 1 MTDH; CHAP31; Esophageal squamous cell carcinoma; Hdac inhibitor; Histone acetylation; LDHB; microRNA; miR 375

Indexed keywords

CXCL1 CHEMOKINE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 132; MICRORNA 146B 5P; MICRORNA 183; MICRORNA 192; MICRORNA 194; MICRORNA 375; MICRORNA 449A; MICRORNA 449B; MICRORNA 497; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE ELEVATED GENE 1; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LOSS OF FUNCTION MUTATION; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; UPREGULATION;

ACETYLATION; AGED; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES, CYCLIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84864987437     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1537     Document Type: Article

References (30)

1. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003. (Pubitemid 37485141)
2. Akutsu Y and Matsubara H: The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today 41: 1190-1195, 2011.
3. National Cancer Institute (Bethesda, MD, USA). The Surveillance, Epidemiology and End Results (SEER) Program. Cancer Statistics Review, 2007.
4. Boumber Y and Issa JP: Epigenetics in cancer: what's the future? Oncology (Williston Park) 25: 220-226, 228, 2011.
5. Hoshino I and Matsubara H: Recent advances in histone deacetylase targeted cancer therapy. Surg Today 40: 809-815, 2010.
6. Hoshino I, Matsubara H, Ochiai T, et al: Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells. Clin Cancer Res 11: 7945-7952, 2005. (Pubitemid 41611642)
7. Murakami K, Matsubara H, Hoshino I, et al: CHAP31 induces apoptosis only via the intrinsic pathway in human esophageal cancer cells. Oncology 78: 62-74, 2010.
8. Hoshino I, Matsubara H, Ochiai T, et al: Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Oncol Rep 18: 85-92, 2007.
9. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006. (Pubitemid 44430905)
11. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
12. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
13. Chiyomaru T, Enokida H, Nakagawa M, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
14. Ichimi T, Enokida H, Seki N, et al: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352, 2009.
15. Nohata N, Hanazawa T, Seki N, et al: Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 56: 595-601, 2011.
16. Sugimoto T, Seki N, Hata A, et al: The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 48: 132-142, 2009.
17. Wagner JM, Hackanson B, Lübbert M, et al: Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 1: 117-136, 2010.
18. Ma X, Ezzeldin HH and Diasio RB: Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69: 1911-1934, 2009.
19. Kano M, Seki N, Matsubara H, et al: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
20. Kikkawa N, Hanazawa T, Seki N, et al: miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer 103: 877-884, 2010.
21. Yoshino H, Chiyomaru T, Nakagawa M, et al: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
22. Kinoshita T, Nohata N, Yoshino H, et al: Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol 40: 185-193, 2012.
23. Li X, Lin R and Li J: Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 56: 2849-2856, 2011.
24. Tsukamoto Y, Nakada C, Moriyama M, et al: MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349, 2010.
25. Kong KL, Kwong DL, Guan XY, et al: MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61: 33-42, 2012.
26. Rountree MR, Bachman KE, Baylin SB, et al: DNA methylation, chromatin inheritance, and cancer. Oncogene 20: 3156-3165, 2001. (Pubitemid 32553571)
27. Zha X, Wang F, Zhang H, et al: Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res 71: 13-18, 2011.
28. Chen Y, Zhang H, Xiao X, et al: Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 54: 95-102, 2006.
29. Hu G, Wei Y and Kang Y: The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620, 2009.
30. Yu C, Chen K, Song L, et al: Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901, 2009.